Yuva Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.12M
- Investors
-
7
Yuva Biosciences General Information
Description
Developer of artificial intelligence-driven compound discovery platforms intended for improving mitochondrial function and addressing cellular aging. The company's platform uses a proprietary AI system trained on experimental data to identify and validate small molecules that influence mitochondrial activity, supports research through in-house and partner-generated datasets, enables integration into cosmetic and therapeutic applications, and provides licensable compounds for formulation into skin and hair-related products, enabling biotechnology and consumer health markets to develop products targeting age-related cellular decline and energy metabolism dysfunction.
Contact Information
Website
www.yuvabio.comCorporate Office
- 1500 First Avenue North
- Suite L133
- Birmingham, AL 35203
- United States
Corporate Office
- 1500 First Avenue North
- Suite L133
- Birmingham, AL 35203
- United States
Yuva Biosciences Timeline
Yuva Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 24-Mar-2026 | $1.12M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Seed Round | 26-Feb-2024 | Completed | Generating Revenue | |||
| 3. Debt - General | 31-Dec-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 06-Aug-2021 | $1.75M | $4.15M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jun-2020 | $2.4M | $2.4M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Yuva Biosciences Comparisons
Industry
Financing
Details
Yuva Biosciences Competitors (3)
One of Yuva Biosciences’s 3 competitors is MitoRx Therapeutics, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MitoRx Therapeutics | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Pretzel Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
| Epirium Bio | Venture Capital-Backed | San Diego, CA |
Yuva Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Yuva Biosciences Patents
Yuva Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026072898-A1 | Compositions and methods for wound and scar healing | Pending | 26-Sep-2024 | ||
| WO-2025064872-A1 | Conjugate compounds for enhancement of mitochondrial health | Inactive | 21-Sep-2023 | ||
| WO-2025064867-A1 | Delivery system for mitochondrial health enhancers | Inactive | 21-Sep-2023 | ||
| EP-4398921-A1 | Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof | Pending | 07-Sep-2021 | ||
| EP-4398921-A4 | Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof | Pending | 07-Sep-2021 | A61K36/03 |
Yuva Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Yuva Biosciences Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ATMA Capital | Venture Capital | Minority | ||
| Western Technology Investment | Venture Capital | Minority | ||
| Longevitytech.fund | Venture Capital | Minority | ||
| Raiz Capital | Venture Capital | Minority | ||
| TBD Angels | Angel Group | Minority |
Yuva Biosciences FAQs
-
When was Yuva Biosciences founded?
Yuva Biosciences was founded in 2019.
-
Where is Yuva Biosciences headquartered?
Yuva Biosciences is headquartered in Birmingham, AL.
-
What is the size of Yuva Biosciences?
Yuva Biosciences has 7 total employees.
-
What industry is Yuva Biosciences in?
Yuva Biosciences’s primary industry is Drug Discovery.
-
Is Yuva Biosciences a private or public company?
Yuva Biosciences is a Private company.
-
What is Yuva Biosciences’s current revenue?
The current revenue for Yuva Biosciences is .
-
How much funding has Yuva Biosciences raised over time?
Yuva Biosciences has raised $13.8M.
-
Who are Yuva Biosciences’s investors?
ATMA Capital, Western Technology Investment, Longevitytech.fund, Raiz Capital, and TBD Angels are 5 of 7 investors who have invested in Yuva Biosciences.
-
Who are Yuva Biosciences’s competitors?
MitoRx Therapeutics, Pretzel Therapeutics, and Epirium Bio are competitors of Yuva Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
